5-(Dimethoxymethyl)-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine

Catalog No. :
ACAEJS630
CAS No. :
2377611-70-4
Molecular Formula :
C14H22BNO4
Molecular Weight :
279.14

IUPAC Name:5-(dimethoxymethyl)-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine

5-(Dimethoxymethyl)-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$117.00Login to see priceInquiryInquiry
1g95%$253.00Login to see priceInquiryInquiry
5g95%$719.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-(Dimethoxymethyl)-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine
IUPAC Name5-(dimethoxymethyl)-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine
MDL No.MFCD28397294
Molecular FormulaC14H22BNO4
Molecular Weight279.14
SMILESCC1(C)C(C)(C)OB(C2=NC=C(C(OC)OC)C=C2)O1
InChI KeyYXJWFYNJBLXZNM-UHFFFAOYSA-N
Synonym5-(Dimethoxymethyl)pyridine-2-boronic acid pinacol ester;5-(Dimethoxymethyl)-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine
CAS No.2377611-70-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACAEJS630 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACAEJS630 route product structure diagram
    ACAEJS6302377611-70-4
Inquiry

2. ACAEJS630 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACAEJS630 route product structure diagram
    ACAEJS6302377611-70-4
Inquiry

Comments (0)